Chemical Manufacturing

NAICS 325 · subsector · PAC industry group on the money pages: Manufacturing & retail

26 laws and 283 sections whose text names, amends, funds or regulates something in this industry or an industry under it.

Automated tagging from the law’s text and public spending records, by fixed published rules; not reviewed by a person. A tag says a section names, amends, funds or regulates something in an industry. It doesn’t say the law helps or hurts that industry. How tags are made

S. 1071 · 119th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
National Defense Authorization Act for Fiscal Year 2026
2 sections · medium confidence
Show 2 sections and the evidence
- Sec. 3111 Organization and codification of provisions of law relating to atomic energy defense activities
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 7261 Policy and briefing on availability of naloxone to treat opioid, including Fentanyl, overdoses
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
S. 331 · 119th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
HALT Fentanyl Act
5 sections · medium confidence
Show 5 sections and the evidence
- Sec. 2 Class scheduling of fentanyl-related substances
  - “21 U.S.C. 812” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 3 Registration requirements related to research
  - “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 4 Technical correction on controlled substances dispensing
  - “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · medium confidence · Source
- Sec. 6 Penalties
  - “21 U.S.C. 841” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 7 Applicability; other matters
  - “21 U.S.C. 841” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
S. 146 · 119th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Tools to Address Known Exploitation by Immobilizing Technological Deepfakes on Websites and Networks Act
1 section · low confidence
Show 1 section and the evidence
- Sec. 2 Criminal prohibition on intentional disclosure of nonconsensual intimate visual depictions
  - “21 U.S.C. 853” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
H.R. 7148 · 119th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Consolidated Appropriations Act, 2026
11 sections · high confidence
Show 11 sections and the evidence
- Sec. 509 (a) None of the funds made available in this Act may be used for…
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
  - “21 U.S.C. 801” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 6221 Medicare coverage of multi-cancer early detection screening tests
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6224 Modernizing and ensuring PBM accountability
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6601 Research into pediatric uses of drugs; additional authorities of Food and Drug Administration regarding molecularly targeted cancer drugs
  - “21 U.S.C. 355c” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 6602 Ensuring completion of pediatric study requirements
  - “21 U.S.C. 355c” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6603 FDA report on PREA enforcement
  - “21 U.S.C. 355c” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6604 Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases
  - “21 U.S.C. 360ff” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6605 Limitations on exclusive approval or licensure of orphan drugs
  - “21 U.S.C. 360cc” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6611 Establishment of Abraham Accords Office within Food and Drug Administration
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 6703 Increasing transparency in generic drug applications
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 7147 · 119th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Homeland Security and Further Additional Continuing Appropriations Act, 2026.
1 section · medium confidence
Show 1 section and the evidence
- Sec. 227 None of the funds made available in this Act for U.S. Customs and Border…
  - “21 U.S.C. 802” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 6938 · 119th Congress
Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026
3 sections · medium confidence
Show 3 sections and the evidence
- The “None” paragraph
  - “15 U.S.C. 2625” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
- The “Administrative Provisions—Environmental Protection Agency” paragraph Administrative Provisions—Environmental Protection Agency
  - “7 U.S.C. 136w” in the text · Rule a (a:usc-7-ch6) · medium confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 435 None of the funds made available by this or any other Act may be…
  - “15 U.S.C. 2601” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
  - “Toxic Substances Control Act” in the text · Rule a (a:act-tsca) · medium confidence · Source
H.R. 6644 · 119th Congress
21st Century ROAD to Housing Act
1 section · medium confidence
Show 1 section and the evidence
- Sec. 202 Whole-Home Repairs Act
  - “15 U.S.C. 2682” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
  - “Toxic Substances Control Act” in the text · Rule a (a:act-tsca) · medium confidence · Source
H.R. 6500 · 119th Congress
Continuing Appropriations and Extensions Act, 2027
1 section · high confidence
Show 1 section and the evidence
- Sec. 2005 Toxic Substances Control Act fee authority
  - “15 U.S.C. 2625” in the text · Rule a (a:usc-15-tsca) · high confidence · Source
  - “Toxic Substances Control Act” in the text · Rule a (a:act-tsca) · medium confidence · Source
H.R. 5371 · 119th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
21 sections · high confidence
Show 21 sections and the evidence
- The “Salaries and Expenses” paragraph Salaries and Expenses
  - “21 U.S.C. 360n” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- The “Buildings and Facilities” paragraph Buildings and Facilities
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- Sec. 722 None of the funds made available by this Act may be used to propose,…
  - “21 U.S.C. 353” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 734 None of the funds made available by this Act may be used to notify…
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 735 None of the funds made available by this or any other Act may be…
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 772 (a) Of the amounts made available in this Act under the heading Department of…
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 773 (a) Fees derived from amounts assessed and collected for fiscal year 2026, credited under…
  - “21 U.S.C. 360n” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 777 For purposes of applying the Federal Food Drug, and Cosmetic Act (21 U.S.C. 301…
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 780 No funds appropriated by this Act may be used to administer or enforce the…
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 781 Effective 365 days after the enactment of this Act, Section 297A of the Agricultural…
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 785 The Commissioner of the Food and Drug Administration shall develop a report to determine…
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 6502 Finding
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6503 Definitions
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6504 Authority to assess and use OTC monograph fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6505 Reauthorization; reporting requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 6506 Treatment of active ingredients for topical administration
  - “21 U.S.C. 355h” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6507 Increasing the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 6508 Regulation of certain nonprescription drugs that are marketed without an approved drug application
  - “21 U.S.C. 355h” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6509 Sunset dates
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6510 Effective date
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 6511 Savings clause
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 2483 · 119th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
SUPPORT for Patients and Communities Reauthorization Act of 2025
6 sections · medium confidence
Show 6 sections and the evidence
- Sec. 112 Assessment of opioid drugs and actions
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 207 Grants to enhance access to substance use disorder treatment
  - “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
- Sec. 209 Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone
  - “21 U.S.C. 811” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 210 References to opioid overdose reversal agents in HHS grant programs
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 401 Delivery of a controlled substance by a pharmacy to a prescribing practitioner
  - “21 U.S.C. 829a” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 402 Required training for prescribers of controlled substances
  - “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
H.R. 1 · 119th Congress
One Big Beautiful Bill Act
4 sections · high confidence
Show 4 sections and the evidence
- Sec. 70511 Termination of clean hydrogen production credit
  - “Section 45V(c)(3)(C)” in the text · Rule d (d:irc-45v) · high confidence · Source
- Sec. 70521 Extension and modification of clean fuel production credit
  - “section 6426(k) of the Internal Revenue Code of 1986” in the text · Rule d (d:irc-40) · high confidence · Source
  - “Section 45Z(f)(1)(A)” in the text · Rule d (d:irc-45z) · high confidence · Source
- Sec. 70522 Restrictions on carbon oxide sequestration credit
  - “Section 45Q(f)” in the text · Rule d (d:irc-45q) · medium confidence · Source
- Sec. 70524 Income from hydrogen storage, carbon capture, advanced nuclear, hydropower, and geothermal energy added to qualifying income of certain publicly traded partnerships
  - “section 6426” in the text · Rule d (d:irc-40) · high confidence · Source
H.R. 9747 · 118th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Continuing Appropriations and Extensions Act, 2025
1 section · high confidence
Show 1 section and the evidence
- Sec. 202 Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases
  - “21 U.S.C. 360ff” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 5860 · 118th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Continuing Appropriations Act, 2024 and Other Extensions Act
13 sections · low confidence
Show 13 sections and the evidence
- Sec. 2301 Short title; finding
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2302 Definitions
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2303 Authority to assess and use animal drug fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2304 Reauthorization; reporting requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2305 Savings clause
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2306 Effective date
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2307 Sunset dates
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2311 Short title; finding
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2312 Authority to assess and use generic new animal drug fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2313 Reauthorization; reporting requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2314 Savings clause
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2315 Effective date
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2316 Sunset dates
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 5009 · 118th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
4 sections · medium confidence
Show 4 sections and the evidence
- Sec. 707 Contraception coverage parity under the TRICARE program
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 739 Plan to improve access by members of the Armed Forces to safe, high-quality pharmaceuticals
  - “Pharmaceutical” in the text · Rule f (f:kw-drugmaker) · low confidence · Source
- Sec. 850 Report and updated guidance on continued risk management for pharmaceutical supply chains of Department of Defense
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 7807 Fentanyl reporting and authorities
  - “21 U.S.C. 802” in the text · Rule a (a:usc-21-csa) · low confidence · Source
H.R. 4366 · 118th Congress
Consolidated Appropriations Act, 2024
3 sections · medium confidence
Show 3 sections and the evidence
- The “Environmental Programs and Management” paragraph Environmental Programs and Management
  - “15 U.S.C. 2625” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
- The “Administrative Provisions—Environmental Protection Agency” paragraph Administrative Provisions—Environmental Protection Agency
  - “7 U.S.C. 136w” in the text · Rule a (a:usc-7-ch6) · medium confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 437 None of the funds made available by this or any other Act may be…
  - “15 U.S.C. 2601” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
  - “Toxic Substances Control Act” in the text · Rule a (a:act-tsca) · medium confidence · Source
H.R. 4366 · 118th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Consolidated Appropriations Act, 2024
7 sections · medium confidence
Show 7 sections and the evidence
- The “Salaries and Expenses” paragraph Salaries and Expenses
  - “21 U.S.C. 360n” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- The “Buildings and Facilities” paragraph Buildings and Facilities
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- The “Fda Innovation Account, Cures Act” paragraph Fda Innovation Account, Cures Act
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- Sec. 722 None of the funds made available by this Act may be used to propose,…
  - “21 U.S.C. 353” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 737 None of the funds made available by this Act may be used to notify…
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 745 (a) After the effective date of any final rule the Food and Drug Administration…
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 754 Out of amounts appropriated to the Food and Drug Administration under title VI, the…
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
H.R. 2882 · 118th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Udall Foundation Reauthorization Act of 2023
3 sections · medium confidence
Show 3 sections and the evidence
- Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
  - “21 U.S.C. 801” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 205 None of the funds made available in this Act for U.S. Customs and Border…
  - “21 U.S.C. 802” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 509 (a) None of the funds made available in this Act may be used for…
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
H.R. 2670 · 118th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
National Defense Authorization Act for Fiscal Year 2024
3 sections · medium confidence
Show 3 sections and the evidence
- Sec. 716 Establishment of military pharmaceutical and medical device vulnerability working group
  - “pharmaceutical” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
- Sec. 723 Program of the Department of Defense to study treatment of certain conditions using certain psychedelic substances
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “21 U.S.C. 812” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 725 Study and report on health conditions of members of the Armed Forces on active duty developed after administration of COVID–19 vaccine
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 815 · 118th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
RELIEVE Act
1 section · low confidence
Show 1 section and the evidence
- Sec. 6 Definitions
  - “21 U.S.C. 812” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
S. 1605 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
National Defense Authorization Act for Fiscal Year 2022
3 sections · medium confidence
Show 3 sections and the evidence
- Sec. 716 Establishment of Department of Defense system to track and record information on vaccine administration
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 744 Briefing on domestic production of critical active pharmaceutical ingredients for national security purposes
  - “pharmaceutical” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
- Sec. 6610 Blocking deadly fentanyl imports
  - “21 U.S.C. 811” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
H.R. 7776 · 117th Congress
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
2 sections · medium confidence
Show 2 sections and the evidence
- Sec. 324 Pilot program on use of sustainable aviation fuel
  - “sustainable aviation fuel” in the heading · Rule f (f:kw-biofuel) · low confidence · Source
- Sec. 7106 Chemical Security Analysis Center
  - “15 U.S.C. 2601” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
  - “Toxic Substances Control Act” in the text · Rule a (a:act-tsca) · medium confidence · Source
H.R. 7776 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
2 sections · low confidence
Show 2 sections and the evidence
- Sec. 860 Risk management for Department of Defense pharmaceutical supply chains
  - “pharmaceutical” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
- Sec. 5558 Definitions
  - “21 U.S.C. 802” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
H.R. 6833 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
34 sections · high confidence
Show 34 sections and the evidence
- Sec. 1001 Short title; finding
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 1002 Definitions
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 1003 Authority to assess and use drug fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 1004 Reauthorization; reporting requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 1005 Sunset dates
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 1006 Effective date
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 1007 Savings clause
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2001 Short title; finding
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2002 Definitions
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2003 Authority to assess and use device fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2004 Reauthorization; reporting requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2005 Conformity assessment pilot program
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2006 Reauthorization of third-party review program
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2007 Sunset dates
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2008 Effective date
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2009 Savings clause
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3001 Short title; finding
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3002 Authority to assess and use human generic drug fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3003 Reauthorization; reporting requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3004 Sunset dates
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3005 Effective date
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3006 Savings clause
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4001 Short title; finding
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4002 Definitions
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4003 Authority to assess and use biosimilar biological product fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4004 Reauthorization; reporting requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4005 Sunset dates
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4006 Effective date
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4007 Savings clause
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 5002 Reauthorization of the humanitarian device exemption incentive
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 5004 Reauthorization of provision pertaining to drugs containing single enantiomers
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 5005 Reauthorization of the critical path public-private partnership
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 5006 Reauthorization of orphan drug grants
  - “21 U.S.C. 360ee” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
- Sec. 5007 Reauthorization of certain device inspections
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 5376 · 117th Congress
Build Back Better Act
8 sections · high confidence
Show 8 sections and the evidence
- Sec. 13104 Extension and modification of credit for carbon oxide sequestration
  - “Section 45Q(d)” in the text · Rule d (d:irc-45q) · medium confidence · Source
- Sec. 13201 Extension of incentives for biodiesel, renewable diesel and alternative fuels
  - “section 6427(e) of such Code” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 13202 Extension of second generation biofuel incentives
  - “Section 40(b)(6)(J)(i)” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 13203 Sustainable aviation fuel credit
  - “section 40A” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 13204 Clean hydrogen
  - “section 45Q” in the text · Rule d (d:irc-45q) · medium confidence · Source
  - “Section 45V(d)” in the text · Rule d (d:irc-45v) · high confidence · Source
  - “Section 6426(d)(2)” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 13701 Clean electricity production credit
  - “section 45Q(f)” in the text · Rule d (d:irc-45q) · medium confidence · Source
- Sec. 13704 Clean fuel production credit
  - “section 45V” in the text · Rule d (d:irc-45v) · high confidence · Source
  - “section 45Q” in the text · Rule d (d:irc-45q) · medium confidence · Source
  - “section 45Z” in the text · Rule d (d:irc-45z) · high confidence · Source
  - “section 6426(k)(3)” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 40007 Alternative fuel and low-emission aviation technology program
  - “sustainable aviation fuel” in the text · Rule f (f:kw-biofuel) · low confidence · Source
H.R. 5376 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Build Back Better Act
9 sections · high confidence
Show 9 sections and the evidence
- Sec. 11001 Providing for lower prices for certain high-priced single source drugs
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
  - “section 5000D of the Internal Revenue Code of 1986” in the text · Rule d (d:irc-drugs) · high confidence · Source
- Sec. 11002 Special rule to delay selection and negotiation of biologics for biosimilar market entry
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 11003 Excise tax imposed on drug manufacturers during noncompliance periods
  - “drug manufacturers” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
- Sec. 11101 Medicare part B rebate by manufacturers
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 11102 Medicare part D rebate by manufacturers
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 11201 Medicare part D benefit redesign
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 11301 Extension of moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates
  - “prescription drug” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
- Sec. 11406 Appropriate cost-sharing for covered insulin products under Medicare part D
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 11408 Safe harbor for absence of deductible for insulin
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
H.R. 3684 · 117th Congress
Investing in a New Vision for the Environment and Surface Transportation in America Act
2 sections · medium confidence
Show 2 sections and the evidence
- Sec. 71102 Electric or low-emitting ferry pilot program
  - “ethanol” in the text · Rule f (f:kw-biofuel) · low confidence · Source
- Sec. 80402 Carbon dioxide capture facilities
  - “Section 45Q(f) of such Code” in the text · Rule d (d:irc-45q) · medium confidence · Source
H.R. 3684 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Investing in a New Vision for the Environment and Surface Transportation in America Act
2 sections · medium confidence
Show 2 sections and the evidence
- Sec. 90004 Requiring manufacturers of certain single-dose container or single-use package drugs payable under part B of the Medicare program to provide refunds with respect to discarded amounts of such drugs
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 90006 Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates
  - “prescription drug” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
H.R. 2617 · 117th Congress
Consolidated Appropriations Act, 2023
16 sections · high confidence
Show 16 sections and the evidence
- The “Environmental Programs and Management” paragraph Environmental Programs and Management
  - “15 U.S.C. 2625” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
- The “Administrative Provisions—Environmental Protection Agency” paragraph Administrative Provisions—Environmental Protection Agency
  - “7 U.S.C. 136w” in the text · Rule a (a:usc-7-ch6) · medium confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 438 None of the funds made available by this or any other Act may be…
  - “15 U.S.C. 2601” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
  - “Toxic Substances Control Act” in the text · Rule a (a:act-tsca) · medium confidence · Source
- Sec. 113 Small immediate financial incentives for contributing to a plan
  - “section 40” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 318 Performance benchmarks for asset allocation funds
  - “section 40” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 331 Special rules for use of retirement funds in connection with qualified federally declared disasters
  - “section 40” in the text · Rule d (d:irc-40) · high confidence · Source
- Sec. 3502 Amendments to cosmetic requirements
  - “21 U.S.C. 361” in the text · Rule a (a:usc-21-cosmetics) · medium confidence · Source
- Sec. 3503 Enforcement and conforming amendments
  - “21 U.S.C. 361” in the text · Rule a (a:usc-21-cosmetics) · high confidence · Source
- Sec. 702 Bilingual labeling
  - “7 U.S.C. 136a” in the text · Rule a (a:usc-7-ch6) · high confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 703 Extension and modification of maintenance fee authority
  - “7 U.S.C. 136a” in the text · Rule a (a:usc-7-ch6) · high confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 704 Reregistration and expedited processing fund
  - “7 U.S.C. 136a” in the text · Rule a (a:usc-7-ch6) · high confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 705 Pesticide registration service fees
  - “7 U.S.C. 136w” in the text · Rule a (a:usc-7-ch6) · high confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 706 Revision of tables regarding covered pesticide registration applications and other covered actions and their corresponding registration service fees
  - “7 U.S.C. 136w” in the text · Rule a (a:usc-7-ch6) · high confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 707 Information
  - “7 U.S.C. 136” in the text · Rule a (a:usc-7-ch6) · medium confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 708 Implementation dates with respect to fees
  - “7 U.S.C. 136w” in the text · Rule a (a:usc-7-ch6) · medium confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 711 Registration review deadline extension
  - “7 U.S.C. 136a” in the text · Rule a (a:usc-7-ch6) · medium confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
H.R. 2617 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Consolidated Appropriations Act, 2023
97 sections · high confidence
Show 97 sections and the evidence
- The “Salaries and Expenses” paragraph Salaries and Expenses
  - “21 U.S.C. 360n” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- The “Buildings and Facilities” paragraph Buildings and Facilities
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- The “Fda Innovation Account, Cures Act” paragraph Fda Innovation Account, Cures Act
  - “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
- Sec. 722 None of the funds made available by this Act may be used to propose,…
  - “21 U.S.C. 353” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 737 None of the funds made available by this Act may be used to notify…
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 763 Out of amounts appropriated to the Food and Drug Administration under title VI, the…
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 774 Notwithstanding any other provision of law, the common name Kanpachi shall serve as an…
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
  - “21 U.S.C. 801” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 205 None of the funds made available in this Act for U.S. Customs and Border…
  - “21 U.S.C. 802” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 509 (a) None of the funds made available in this Act may be used for…
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 112 Compliance with requirements for examining qualifications and clinical abilities of health care professionals of Department of Veterans Affairs
  - “21 U.S.C. 822” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 1219 Grants for reducing overdose deaths
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 1220 Opioid overdose reversal medication access and education grant programs
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 1252 Changes to Federal opioid treatment standards
  - “21 U.S.C. 822” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 1262 Eliminating additional requirements for dispensing narcotic drugs in schedule III, IV, and V for maintenance or detoxification treatment
  - “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 1263 Requiring prescribers of controlled substances to complete training
  - “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 1264 Increase in number of days before which certain controlled substances must be administered
  - “21 U.S.C. 829a” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 1271 Opioid prescription verification
  - “21 U.S.C. 829” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
- Sec. 1273 Grant program for State and Tribal response to opioid use disorders
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2311 Improving control and oversight of select biological agents and toxins
  - “42 U.S.C. 262a” in the text · Rule a (a:usc-42-biologics) · high confidence · Source
- Sec. 2314 Research to improve biosafety
  - “42 U.S.C. 262a” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
- Sec. 2315 Federally-funded research with enhanced pathogens of pandemic potential
  - “42 U.S.C. 262a” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
- Sec. 2331 Advanced Research Projects Agency–Health
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 2401 Warm base manufacturing capacity for medical countermeasures
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2410 Study on incentives for domestic production of generic medicines
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
- Sec. 2411 Increased manufacturing capacity for certain critical antibiotic drugs
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2501 Accelerating countermeasure development and review
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2502 Third party test evaluation during emergencies
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2503 Platform technologies
  - “21 U.S.C. 356j” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · medium confidence · Source
- Sec. 2504 Increasing EUA decision transparency
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2505 Improving FDA guidance and communication
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 2511 Ensuring registration of foreign drug and device manufacturers
  - “21 U.S.C. 360” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2512 Extending expiration dates for certain drugs
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2513 Combating counterfeit devices
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2514 Preventing medical device shortages
  - “21 U.S.C. 356j” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2515 Technical corrections
  - “21 U.S.C. 356c” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3101 Reauthorization of the critical path public-private partnership
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3103 Reauthorization of the humanitarian device exemption incentive
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3105 Reauthorization of provision pertaining to drugs containing single enantiomers
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3106 Reauthorization of certain device inspections
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3107 Reauthorization of orphan drug grants
  - “21 U.S.C. 360ee” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
- Sec. 3109 Reauthorization of third-party review program
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3201 Prompt reports of marketing status by holders of approved applications for biological products
  - “21 U.S.C. 356i” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3202 Improving the treatment of rare diseases and conditions
  - “21 U.S.C. 360bb” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3203 Emerging technology program
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3204 National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3205 Public workshop on cell therapies
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3206 Clarifications to exclusivity provisions for first interchangeable biosimilar biological products
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · high confidence · Source
- Sec. 3207 GAO report on nonprofit pharmaceutical organizations
  - “pharmaceutical” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
- Sec. 3209 Animal testing alternatives
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3210 Modernizing accelerated approval
  - “21 U.S.C. 356” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3211 Antifungal research and development
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3212 Advancing qualified infectious disease product innovation
  - “21 U.S.C. 355f” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3213 Advanced manufacturing technologies designation program
  - “21 U.S.C. 351” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3221 Safer disposal of opioids
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3222 Therapeutic equivalence evaluations
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3223 Public docket on proposed changes to third-party vendors
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3224 Enhancing access to affordable medicines
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3301 Dual submission for certain devices
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3303 GAO report on third-party review
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3304 Certificates to foreign governments
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3305 Ensuring cybersecurity of medical devices
  - “21 U.S.C. 351” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3306 Bans of devices for one or more intended uses
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3307 Third party data transparency
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3308 Predetermined change control plans for devices
  - “21 U.S.C. 360” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3309 Small business fee waiver
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3401 Protecting infants and improving formula supply
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3502 Amendments to cosmetic requirements
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3503 Enforcement and conforming amendments
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3504 Records inspection
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3601 Diversity action plans for clinical studies
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3602 Guidance on diversity action plans for clinical studies
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3604 Annual summary report on progress to increase diversity in clinical studies
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3605 Public meeting on clinical study flexibilities initiated in response to COVID–19 pandemic
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3607 Modernizing clinical trials
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3611 Device inspections
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3612 Bioresearch monitoring inspections
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3613 Improving Food and Drug Administration inspections
  - “21 U.S.C. 360” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 3614 GAO report on inspections of foreign establishments manufacturing drugs
  - “21 U.S.C. 360” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3615 Unannounced foreign facility inspections pilot program
  - “21 U.S.C. 351” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3616 Enhancing coordination and transparency on inspections
  - “21 U.S.C. 356d” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3617 Enhancing transparency of drug facility inspection timelines
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3621 Regulation of certain products as drugs
  - “21 U.S.C. 353” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3622 Women’s Health Research Roadmap
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3623 Strategic workforce plan and report
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3624 Enhancing Food and Drug Administration hiring authority for scientific, technical, and professional personnel
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 3625 Facilities management
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3626 User fee program transparency and accountability
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 3627 Improving information technology systems of the Food and Drug Administration
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 3628 Reporting on mailroom and Office of the Executive Secretariat of the Food and Drug Administration
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 3629 Facilitating the use of real world evidence
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 3630 Facilitating exchange of product information prior to approval
  - “21 U.S.C. 352” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4131 Temporary inclusion of authorized oral antiviral drugs as covered part D drug
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 4135 Access to non-opioid treatments for pain relief
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 502 Increasing access to summer meals for children through EBT and alternative delivery options
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 703 Extension and modification of maintenance fee authority
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 706 Revision of tables regarding covered pesticide registration applications and other covered actions and their corresponding registration service fees
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · medium confidence · Source
H.R. 2471 · 117th Congress
Consolidated Appropriations Act, 2022
4 sections · medium confidence
Show 4 sections and the evidence
- The “Environmental Programs and Management” paragraph Environmental Programs and Management
  - “15 U.S.C. 2625” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
- The “None” paragraph
  - “7 U.S.C. 136w” in the text · Rule a (a:usc-7-ch6) · medium confidence · Source
  - “Federal Insecticide, Fungicide, and Rodenticide Act” in the text · Rule a (a:act-fifra) · medium confidence · Source
- Sec. 438 None of the funds made available by this or any other Act may be…
  - “15 U.S.C. 2601” in the text · Rule a (a:usc-15-tsca) · medium confidence · Source
  - “Toxic Substances Control Act” in the text · Rule a (a:act-tsca) · medium confidence · Source
- Sec. 7044 (a) Afghanistan (1) None of the funds appropriated by this Act and prior Acts…
  - “fertilizer” in the text · Rule f (f:kw-chemicals) · low confidence · Source
H.R. 2471 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
Consolidated Appropriations Act, 2022
10 sections · medium confidence
Show 10 sections and the evidence
- The “Salaries and Expenses” paragraph Salaries and Expenses
  - “21 U.S.C. 360n” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 737 None of the funds made available by this Act may be used to notify…
  - “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 766 None of the funds made available by this Act may be used to propose,…
  - “21 U.S.C. 353” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 768 Out of amounts appropriated to the Food and Drug Administration under title VI, the…
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
- Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
  - “21 U.S.C. 801” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 205 None of the funds made available in this Act for U.S. Customs and Border…
  - “21 U.S.C. 802” in the text · Rule a (a:usc-21-csa) · low confidence · Source
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 509 (a) None of the funds made available in this Act may be used for…
  - “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
- Sec. 111 FDA authority over products containing nicotine
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 112 Reporting on tobacco regulation activities
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
  - “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- Sec. 121 Eligibility exception for the drug discount program due to the COVID–19 public health emergency
  - “42 U.S.C. 256b” in the text · Rule a (a:usc-42-340b) · medium confidence · Source
H.R. 1319 · 117th Congress · tagged 3254 Pharmaceutical and Medicine Manufacturing
American Rescue Plan Act of 2021
3 sections · medium confidence
Show 3 sections and the evidence
- Sec. 2301 Funding for COVID–19 vaccine activities at the Centers for Disease Control and Prevention
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2302 Funding for vaccine confidence activities
  - “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
  - “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- Sec. 2304 Funding for COVID–19 vaccine, therapeutic, and device activities at the Food and Drug Administration
  - “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source

32 law-and-industry pairs in all, newest Congress first.